Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Biogen Inc

3 No-Brainer Stocks to Buy Right Now Without Hesitation

Cooling inflation data and Fed’s recent 25 bps rate hike have contributed considerably to optimistic investor sentiment in the past few weeks. However, as opposed to an expected pause, the robust jobs report has raised prospects of further rate hikes in the coming months. Therefore, it could be wise to…

StockNews.com

3 Stocks to Get Bullish on Now

The Fed’s recent 25 bps rate hike in response to cooling inflation and Powell’s dovish comments improved investor sentiment. Amid growing optimism over the slowing interest rate hikes, we think fundamentally strong stocks Archer-Daniels-Midland (ADM), Biogen (BIIB), and MasterCraft (MCFT) are ideal additions to one’s portfolio. Read on….

StockNews.com

3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Top-Rated Stocks to Buy for the Long Haul

Amid economic turmoil and recessionary fears, market volatility is anticipated to continue. However, this could be an opportune time for investors to scoop up quality top-rated stocks Gilead Sciences (GILD), Biogen (BIIB), and AudioCodes (AUDC) for the long haul. Read on….

StockNews.com

Sitting on Cash? These 3 Stocks Are Great Buys Right Now

The U.S. economy is gripped by fears of an economic slowdown due to several macroeconomic and geopolitical headwinds. However, the uncertain market conditions have created opportunities for investors sitting on cash to buy quality stocks at attractive prices. Biogen (BIIB), AutoNation (AN), and AdvanSix (ASIX), which are trading at discounts…

StockNews.com

3 Nasdaq Stocks You'll Regret Not Buying This Year

Although macroeconomic headwinds kept the stock market under immense pressure last year, the declining inflation rates have increased investor optimism recently. Hence, quality Nasdaq stocks Comcast Corporation (CMCSA), Honeywell International (HON), and Biogen (BIIB) might be solid buys this year. Read on….

StockNews.com

3 Biotech Stocks to Help Boost Your Portfolio in January

Increased government initiatives and the rising adoption of biotechnology in healthcare and agriculture are likely to enhance the growth of the biotech industry. Hence, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal additions to your portfolio as they look well-positioned to capitalize…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Value Stocks Worth Your Attention in 2023

With the Fed slated to increase rates aggressively this year to curb inflation, value stocks could shine again. Thus, investors could invest in shares of fundamentally strong stocks Biogen (BIIB), Dow Inc. (DOW), and Albertsons Companies (ACI) that are trading at attractive valuations. Continue reading….

StockNews.com

3 Stocks to Buy Like There's No Tomorrow

While inflation eased considerably for two consecutive months, the Fed signaled to keep raising interest rates through this year. The potential continuation of rate hikes has fueled recessionary concerns. Amid an uncertain macroeconomic backdrop, it could be wise to buy fundamentally strong stocks Merck (MRK), Biogen (BIIB), and MasterCraft Boat…

StockNews.com

FDA’s approval of Biogen Alzheimer’s drug slammed in report

U.S. health officials’ approval process for Biogen Inc.’s controversial Alzheimer’s drug was “rife with irregularities,” raising serious concerns about protocol lapses at the agency, congressional investigators said.

Tribune News Service

4 Warren Buffett Stocks to Buy and Never Sell

Legendary investor Warren Buffett’s holding company Berkshire Hathaway has outperformed the broader market over the past year. His investment portfolio has been a guide for several long-term investors for decades. Amid a highly uncertain market and economic backdrop, Warren Buffett holdings Procter & Gamble (PG), AbbVie (ABBV), Biogen (BIIB), and…

StockNews.com

2 Biotech Stock to Buy Over Moderna This December

Biotech giant Moderna (MRNA) missed consensus revenue and EPS estimates in its 2022 third quarter. Moreover, it lost more than 17% in 2022. While analysts are bearish on MRNA’s growth, the industry prospects look bright. Therefore, investors looking to invest in biotech stocks could consider buying Biogen (BIIB) and Jazz…

StockNews.com

3 Biotech Stocks to Help You Build a Healthy Portfolio

Biotech industry played a vital role amid the pandemic and continues to witness solid demand amid rising medical needs and chronic diseases. Investor sentiment toward biotech stocks is robust. As biotech is considered a defensive sector against market downturns, investors might buy quality biotech stocks Gilead Sciences (GILD), Biogen (BIIB),…

StockNews.com

Wall Street Loves This 1 Strong Buy Stock Right Now

Wall Street looks bullish on Biogen’s (BIIB) prospects after the company’s success during the Phase 3 clinical trial of lecanemab. The drug could boost the company’s financials significantly as it could herald a new era for people with Alzheimer’s disease. Its bright growth prospects have earned it a Strong Buy…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Stocks Insiders Are Buying up Right Now

Insider buying is considered a reliable indicator of a company’s prospects since insiders have the most up-to-date knowledge about the company’s inner workings and its outlook that could be unknown to analysts and investors. Insiders have been buying up shares of Coca-Cola (KO), Biogen (BIIB), and Pure Storage (PSTG) of…

StockNews.com

3 Stocks You'll Regret Not Buying This Year

With slowing inflation, indications of slower rate hikes by the Fed beginning this month, and resilient employment growth, fundamentally strong stocks Biogen (BIIB), APA Corporation (APA), and Nathan’s Famous (NATH) seem to be good investments now. Continue reading….

Tribune News Service

Lisa Jarvis: That blockbuster Alzheimer’s drug? It’s not a cure

Biogen Inc. and Eisai Co. caused a stir in September when they announced positive results in a late-stage trial for a closely watched Alzheimer’s drug, lecanemab. Doctors tempered their excitement, though, until they could scrutinize the full peer-reviewed data.

StockNews.com

2 Biotech Stocks to Add to Your Portfolio in Q4

Despite lingering macro issues, the biotech industry is expected to witness robust growth. Moreover, amid rising medical needs and chronic diseases, research and development in the biotech sector are expected to expand, contributing to its growth. Therefore, investors might add quality biotech stocks Gilead Sciences (GILD) and Biogen (BIIB) to…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Stocks to Buy This Month if You Haven’t Already

Although the stock market has seen a decline in inflation for October, it is far from the Fed’s target, and rate hikes might continue. However, the anticipation of a strong stock market rebound in 2023 is rising. So, we think it could be wise to load up on fundamentally sound…

StockNews.com

2 Stocks You Could Keep in Your Portfolio Forever

Despite signs of inflation cooling in the United States, the IMF is not expecting the global economic picture to improve anytime soon. However, the cooling inflation might induce the Fed to ease the pace of rate hikes. As economic uncertainties remain, we think fundamentally solid stocks McDonald’s (MCD) and Biogen…

StockNews.com

The 4 Best Stocks to Buy This November

Favorable inflation data for October has raised the odds of slower federal rate hikes ahead. The market has been celebrating the inflation report, and experts believe the current rally could sustain for a while. Therefore, investors could buy quality stocks such as Gilead Sciences (GILD), Biogen (BIIB), Hillenbrand (HI), and…

StockNews.com

4 Stocks You Can Purchase at a Discount in Q4

Aggressive monetary policy tightening by the Fed and red-hot inflation have led to a broad stock market sell-off this year. However, the Fed is expected to slow the pace of rate hikes in the coming months. Therefore, it could be the right time to invest in fundamentally solid stocks Oracle…

StockNews.com

4 Nasdaq Stocks You'll Never Regret Buying

Amid the Fed's consecutive rate hikes, the Nasdaq composite has lost more than 30% year-to-date. However, it has gained marginally over the past month. Moreover, the Fed is expected to slow down the pace of rate hikes in the upcoming terms. Therefore, we think investors could consider buying quality Nasdaq…

StockNews.com

3 Strong Buy Stocks Begging to Be Bought in Q4

The Federal Reserve announced its fourth consecutive 75-bps rate hike yesterday. As the chances of the economy falling into a recession are tightening, fundamentally strong and resilient stocks Merck & Co (MRK), Biogen (BIIB), and Kroger (KR), which are rated Strong Buy in our proprietary rating system, could be safe…

StockNews.com

Despite fears of another major interest rate hike by the Fed in response to the stubborn inflation data for September, stocks such as Microsoft (MSFT) and Biogen (BIIB) have shown remarkable stability. Hence, it may be the right time to invest in them for market-beating returns. Keep reading.

1 2 3 4

People

Dipanjan BanchurSince

722 stories

Kritika SarmahHer

694 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

Sristi Suman Jayaswal

90 stories

Lisa Jarvis

27 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.